Denmark Hearing Loss Disease Treatment Market Size & Outlook
Denmark hearing loss disease treatment market, 2018-2030 (US$M)
Related Markets
Denmark hearing loss disease treatment market highlights
- The Denmark hearing loss disease treatment market generated a revenue of USD 134.2 million in 2023 and is expected to reach USD 185.0 million by 2030.
- The Denmark market is expected to grow at a CAGR of 4.7% from 2024 to 2030.
- In terms of segment, devices was the largest revenue generating product in 2023.
- Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
Hearing loss disease treatment market data book summary
| Market revenue in 2023 | USD 134.2 million |
| Market revenue in 2030 | USD 185.0 million |
| Growth rate | 4.7% (CAGR from 2023 to 2030) |
| Largest segment | Devices |
| Fastest growing segment | Drugs |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Devices, Drugs |
| Key market players worldwide | Novartis AG ADR, Frequency Therapeutics, Acousia Therapeutics, Sensorion, Pipeline Therapeutics, Audina Hearing Instruments, Astellas Pharma Inc |
Other key industry trends
- In terms of revenue, Denmark accounted for 1.0% of the global hearing loss disease treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany hearing loss disease treatment market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 2,083.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hearing Loss Disease Treatment Market Scope
Hearing Loss Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Denmark hearing loss disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hearing loss disease treatment market will help companies and investors design strategic landscapes.
Devices was the largest segment with a revenue share of 90.98% in 2023. Horizon Databook has segmented the Denmark hearing loss disease treatment market based on devices, drugs covering the revenue growth of each sub-segment from 2018 to 2030.
High prevalence of hearing loss, rise in awareness about advanced technologies, and technological advancements in hearing aids are contributing to the Denmark hearing loss treatment market. In February 2023, Oticon, one of the major hearing aids manufacturer introduced Oticon Real.
This new device is equipped with noise cancellation and balancing technology. Furthermore, in February 2023, GN Hearing announced expansion of its well-known ReSound OMNIA product portfolio to provide extended devices with enhanced capabilities.
In addition, companies are also actively focusing on expansion of facilities and infrastructure to consolidate market presence in Denmark. For instance, in November 2020, CILcare, one of the leading CROs fully operating in the ear disorders arena, opened a new subsidiary in Copenhagen, Denmark.
Reasons to subscribe to Denmark hearing loss disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Denmark hearing loss disease treatment market databook
-
Our clientele includes a mix of hearing loss disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark hearing loss disease treatment market, including forecasts for subscribers. This country databook contains high-level insights into Denmark hearing loss disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Denmark hearing loss disease treatment market report size, by product, 2018-2030 (US$M)
Denmark Hearing Loss Disease Treatment Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
